Friday, April 3, 2026

North Korea Denounces U.S.-South Korea Military Exercise Adjustments as “Deception”

North Korea criticizes U.S.-South Korea military exercise adjustments, claiming they are deceptive and do not reduce tensions on the peninsula.

North Korea Hits Back at U.S. Human Rights Accusations

North Korea recently criticized the U.S. over...

Watcha Launches Shortcha in U.S. Amid Explosive 8000% Market Growth

Watcha launches Shortcha in the U.S., tapping into the booming short-form drama market with diverse global content offerings.

Tag: cancer drug

HLB’s Liragratinib: A Game-Changer in Cholangiocarcinoma Treatment Revealed at ASCO GI 2026!

HLB's lirafugratinib shows promise as a precision oncology drug, targeting FGFR2 in cancer treatment. FDA application expected soon.

Top News

- Our Sponsors Ad -

Follow us